The Kidney Research Institute of Texas supports kidney health investment in Houston.

Uncategorized

The Kidney Research Institute of Texas continues to press forward to develop programs designed to accelerate investment in kidney disease prevention, including nutritional and dietary management programs for elementary grade school students as well as for adults, kidney disease research, and technology innovation to improve the lives of kidney patients. We are committed to ending the worldwide kidney disease pandemic. According to the National Kidney Foundation, one-third of the world’s adult population is at risk for kidney disease.

Our goal is to help make the Houston medical and health care community the world leader in kidney health investment and take the leadership role, worldwide, in investments for kidney disease prevention, kidney disease research, and technology innovation to improve the lives of kidney patients.

We continue to meet with the leading Nephrology and Kidney Research Teams in The Texas Medical Center in Houston to advance our goal and vision of accelerating investment in kidney disease prevention, kidney disease research, and technology innovation to improve the lives of kidney patients. These activities are ongoing.

Bill Gottfried is honored to serve as a Ambassador for the American Association of Kidney Patients and Dialysis Patient Citizens where he works to support investment in kidney health to improve the lives of kidney patients. Bill has been a fundraiser for the National Kidney Foundation.

Unknown's avatar

Published by Bill and Danielle Gottfried, Founders of The Kidney Research Institute of Texas

Bill and Danielle Gottfried established The Kidney Research Institute of Texas in Houston; we are committed to finding the cure for kidney disease. Bill's Father, Henry William Gottfried, Jr., died early in his life from kidney failure and Bill has had other Family members afflicted by kidney disease. Danielle has had Family members suffer from kidney disease and kidney failure. Our goal is to raise investments that will be allocated directly to the leading kidney research and kidney dialysis technology innovation teams in Houston, around the U.S., and worldwide that are conducting leading edge research on finding the cure for kidney disease and improving patient care. Bill Gottfried has been involved in the biotechnology industry since the early 1980's, the dawn of the biotechnology era. He has supported biotechnology and health care investment in the U.S., Europe, and Asia, and he recruited the management team for the first biotechnology company that was established in Houston. Bill has provided capital formation, executive search, and strategic planning expertise to biotechnology industry clients for over 30 years. He was a founding member of BIOHouston and the Biotechnology Industry Organization in Washington, D.C.

Published

Leave a comment